297 related articles for article (PubMed ID: 3512855)
1. In vitro experimental infection of primary duck hepatocyte cultures with duck hepatitis B virus.
Tuttleman JS; Pugh JC; Summers JW
J Virol; 1986 Apr; 58(1):17-25. PubMed ID: 3512855
[TBL] [Abstract][Full Text] [Related]
2. Duck hepatitis B virus replication in primary bile duct epithelial cells.
Lee JY; Culvenor JG; Angus P; Smallwood R; Nicoll A; Locarnini S
J Virol; 2001 Aug; 75(16):7651-61. PubMed ID: 11462037
[TBL] [Abstract][Full Text] [Related]
3. The carbocyclic analog of 2'-deoxyguanosine induces a prolonged inhibition of duck hepatitis B virus DNA synthesis in primary hepatocyte cultures and in the liver.
Fourel I; Saputelli J; Schaffer P; Mason WS
J Virol; 1994 Feb; 68(2):1059-65. PubMed ID: 8289335
[TBL] [Abstract][Full Text] [Related]
4. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
5. Duck hepatitis B virus infection of Muscovy duck hepatocytes and nature of virus resistance in vivo.
Pugh JC; Simmons H
J Virol; 1994 Apr; 68(4):2487-94. PubMed ID: 7511172
[TBL] [Abstract][Full Text] [Related]
6. Virus-neutralizing monoclonal antibody to a conserved epitope on the duck hepatitis B virus pre-S protein.
Lambert V; Fernholz D; Sprengel R; Fourel I; Deléage G; Wildner G; Peyret C; Trépo C; Cova L; Will H
J Virol; 1990 Mar; 64(3):1290-7. PubMed ID: 1689393
[TBL] [Abstract][Full Text] [Related]
7. Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus model.
Bishop N; Civitico G; Wang YY; Guo KJ; Birch C; Gust I; Locarnini S
J Med Virol; 1990 Jun; 31(2):82-9. PubMed ID: 2388048
[TBL] [Abstract][Full Text] [Related]
8. The half-life of duck hepatitis B virus supercoiled DNA in congenitally infected primary hepatocyte cultures.
Civitico GM; Locarnini SA
Virology; 1994 Aug; 203(1):81-9. PubMed ID: 8030288
[TBL] [Abstract][Full Text] [Related]
9. Endotoxin stimulates liver macrophages to release mediators that inhibit an early step in hepadnavirus replication.
Klöcker U; Schultz U; Schaller H; Protzer U
J Virol; 2000 Jun; 74(12):5525-33. PubMed ID: 10823858
[TBL] [Abstract][Full Text] [Related]
10. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement.
Jilbert AR; Wu TT; England JM; Hall PM; Carp NZ; O'Connell AP; Mason WS
J Virol; 1992 Mar; 66(3):1377-88. PubMed ID: 1738197
[TBL] [Abstract][Full Text] [Related]
11. Replication of duck hepatitis B virus in primary duck hepatocytes and its dependence on the state of differentiation of the host cell.
Galle PR; Schlicht HJ; Kuhn C; Schaller H
Hepatology; 1989 Oct; 10(4):459-65. PubMed ID: 2777207
[TBL] [Abstract][Full Text] [Related]
12. DNA vaccines expressing the duck hepatitis B virus surface proteins lead to reduced numbers of infected hepatocytes and protect ducks against the development of chronic infection in a virus dose-dependent manner.
Miller DS; Kotlarski I; Jilbert AR
Virology; 2006 Jul; 351(1):159-69. PubMed ID: 16624364
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.
Miller DS; Halpern M; Kotlarski I; Jilbert AR
Virology; 2006 May; 348(2):297-308. PubMed ID: 16469347
[TBL] [Abstract][Full Text] [Related]
14. Characterization of age- and dose-related outcomes of duck hepatitis B virus infection.
Jilbert AR; Botten JA; Miller DS; Bertram EM; Hall PM; Kotlarski J; Burrell CJ
Virology; 1998 May; 244(2):273-82. PubMed ID: 9601498
[TBL] [Abstract][Full Text] [Related]
15. Entecavir therapy combined with DNA vaccination for persistent duck hepatitis B virus infection.
Foster WK; Miller DS; Marion PL; Colonno RJ; Kotlarski I; Jilbert AR
Antimicrob Agents Chemother; 2003 Aug; 47(8):2624-35. PubMed ID: 12878529
[TBL] [Abstract][Full Text] [Related]
16. Transbody against virus core protein potently inhibits hepadnavirus replication in vivo: evidence from a duck model of hepatitis B virus.
Li Y; Liu Z; Hui L; Liu X; Feng A; Wang W; Zhang L; Li N; Zhou G; Wang Q; Han Q; Lv Y; Wang Q; Yang G; Wang Y
Br J Pharmacol; 2017 Jul; 174(14):2261-2272. PubMed ID: 28383135
[TBL] [Abstract][Full Text] [Related]
17. Naturally occurring infection of Pekin duck embryos by duck hepatitis B virus.
O'Connell AP; Urban MK; London WT
Proc Natl Acad Sci U S A; 1983 Mar; 80(6):1703-6. PubMed ID: 6572934
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of early molecular events in duck hepatitis B virus replication in primary duck hepatocytes.
Qiao M; Scougall CA; Duszynski A; Burrell CJ
J Gen Virol; 1999 Aug; 80 ( Pt 8)():2127-2135. PubMed ID: 10466812
[TBL] [Abstract][Full Text] [Related]
19. Decrease of wild-type and precore mutant duck hepatitis B virus replication during lamivudine treatment in white Pekin ducks infected with the viruses.
Tomita T; Yokosuka O; Tagawa M; Saisho H; Tamura S; Fukuda I; Omata M
J Hepatol; 2000 May; 32(5):850-8. PubMed ID: 10845674
[TBL] [Abstract][Full Text] [Related]
20. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
